NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the investor presentation issued by Alcon Inc. (“Alcon”) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (“STAAR” o…
Category: News
Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
Ocular Rosacea Underappreciated in Dermatology and Beyond
For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and applying treatments they are already using. Medscape Medical News
Systemic Therapy for Sjögren Closer With Phase 3 Success
Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrate improvement in disease activity. Medscape Medical News
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced the successf…
Glaukos Announces Participation in Upcoming Investor Conferences
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Chemotherapy Drug Shortages Become Cancer-Care Reality
Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say. Medscape Medical News
HTC and IngenioSpec Settled ITC Dispute on Electronic Eyewear Products
WACO, Texas–(BUSINESS WIRE)– #audio–IngenioSpec Resolves Patent Dispute with HTC on Electronic Eyewear Technology.
Study: Poor Screen, Sleep Hygiene Drying Out Kids’ Eyes
A study of more than 1300 children found dry eye disease has increased dramatically over the past 5 years and is linked to more screen time and less sleep. Medscape Medical News
Advancing Sight Network Receives $25,000 Grant from EyeSight Foundation of Alabama to Pursue Cures for Vision Loss
BIRMINGHAM, Ala.–(BUSINESS WIRE)–Advancing Sight Network, an Alabama-based nonprofit dedicated to preserving and restoring eyesight, has received a $25,000 grant from the EyeSight Foundation of Alabama and the Community Foundation of Greater Birmingh…
Tocilizumab May Be Better Than MTX for GCA at 1 Year
At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in maintaining remission and preventing relapse. Medscape Medical News
GenSight Biologics Announces Regulatory Authorizations for Individual Patient Expanded Access Treatment with GS010/LUMEVOQ® in the US
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
McDonald Criteria Updates Boost MS Diagnostic Specificity
Dr Andrew Solomon discusses changes to the 2024 McDonald criteria that can improve diagnostic specificity and early detection in multiple sclerosis. Consortium of Multiple Sclerosis Centers
Samsung Bioepis to Commercialize BYOOVIZ® (ranibizumab) in Europe from January 2026
INCHEON, Korea–(BUSINESS WIRE)– #BYOOVIZ–Samsung Bioepis Co., Ltd. announced today that the company has entered into an Asset Purchase Agreement (APA) with Biogen regarding Samsung Bioepis’ two ophthalmology assets: BYOOVIZ® (ranibizumab), a biosimi…
Can Statins Prevent This Complication of Retinal Surgery?
A large database study of eyes that had retinal detachment surgery supports what smaller studies have found: People on statins have fewer post-op complications. Medscape Medical News
Targeted T-cell Therapy Beneficial in Rare Form of Melanoma
Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, despite them not being amenable to traditional immunotherapy, suggests trial. Medscape Medical News
Targeted T-Cell Therapy Beneficial in Rare Form of Melanoma
Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, despite them not being amenable to traditional immunotherapy, suggests trial. Medscape Medical News
Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced achievement of statis…
AMD Progression Post-Cataract Surgery: Real but Small Risk
One of the largest studies of cataract surgery in people with dry age-related macular degeneration finds a small risk for conversion to the wet form of the disease. Medscape Medical News
Subretinal Implant Improves Vision in Advanced Dry AMD
A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular degeneration. Medscape Medical News